Biosplice Therapeutics

Biosplice Therapeutics, Inc. (formerly Samumed, LLC) is a private biopharmaceutical company based in San Diego, California. It was founded in 2008 by Osman Kibar.[1]

Biosplice Therapeutics
TypePrivately held company
IndustryRegenerative medicine
Founded2008 (2008) in San Diego, USA
FounderOsman Kibar
Faterenamed from Samumed
Headquarters
San Diego, USA
Websitewww.biosplice.com

Samumed's products in development target novel components of the Wnt signaling pathway.[2][3][4] The company focuses on potential treatments for several diseases; its osteoarthritis program is its most advanced.[3][5]

References


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.